THE CHALLENGES FOR MANUFACTURERS OF THE INCREASED CLINICAL EVALUATION REQUIREMENTS UNDER THE EUROPEAN UNION MEDICAL DEVICE REGULATIONS

The European Union Medical Device Regulations EU MDR established new demanding clinical evaluation criteriathat substantially affect medical equipment manufacturers. The EU MDR imposes rules that require manufacturers toprovide advanced clinical proof and maintain continuous surveillance of their products under strict notification bodyoversight. Manufacturers encounter multiple obstacles due to the enhancements that were introduced to improvepatient safety and device effectiveness. In addition, the shortage of approved notified bodies causes delays in marketentry for new devices and existing products. Small and medium-sized enterprises (SMEs) face adverse effects fromcompliance costs, which leads them to eliminate products or stop selling in markets. Companies face challenges toinnovation since they must dedicate substantial resources to fulfill transforming regulatory standards. The followingstudy provides a deep examination of these regulatory challenges, including their industrial effects on the medicaldevice sector, along with manufacturer-approved navigation strategies.